large-scale prediction testing drug activity side-effect targets 
discovering unintended off-targets predict adverse drug reactions daunting empirical methods alone drugs can act several protein targets can unrelated conventional molecular metrics hundreds proteins implicated side effects use computational strategy predict activity marketed drugs unintended side-effect targets approximately half predictions confirmed either proprietary databases unknown method new experimental assays affinities new off-targets ranged 1nm mu m explore relevance developed association metric prioritize new off-targets explained side effects better known target given drug creating drug-target-adverse drug reaction network among new associations prediction abdominal pain side effect synthetic oestrogen chlorotrianisene mediated newly discovered inhibition enzyme cyclooxygenase- clinical relevance inhibition borne whole human blood platelet aggregation assays approach may wide application de-risking toxicological liabilities drug discovery 
